Edap TMS Sa News

The company offers its products and services through its two divisions, namely, High Intensity Focused Ultrasound and Urology Devices and Services .

Healthcare stocks are generally considered as defensive stocks. So investors looking for a place to hide in the current volatile equity markets can consider this sector.

Received U.S. FDA 510 marketing clearance in August 2011 for Sonolith i-move device, a technologically advanced compact mobile lithotripter -- Obtained marketing approval in Japan in June 2011 for Sonolith i-move -- Drove market demand for renewed lithotripsy product range with significant lithotripsy backlog with up to fifteen devices -- Advancing ... (more)

Largest Long-Term Study Confirms EDAP's Ablatherm HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer -- 2,552 Patient, International, Multi-Center, 10-year Study Shows 83% of Patients Cancer Free -- LYON, France, May 17, 2011 LYON, France , May 17, 2011 /PRNewswire/ -- EDAP TMS SA , the global leader in ...

Equities research analysts at Zacks Investment Research reiterated a "neutral" rating on shares of Edap - Tms SA in a research note to investors on Thursday.